Nadler Financial Group, Inc. Ptc Therapeutics, Inc. Transaction History

Nadler Financial Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 19, 2023	BUY	$38.16 - $48.86 $188,472 - $241,319	4,939 New	4,939 $239,000
Q3 2022 Oct 31, 2022	BUY	$41.85 - $53.85 $206,697 - $265,965	4,939 New	4,939 $248,000
Q2 2022 Jul 20, 2022	SELL	$25.6 - $45.23 $164,172 - $290,059	-6,413 Closed	0 $0
Q3 2019 Oct 03, 2019	BUY	$33.82 - $48.17 $216,887 - $308,914	6,413 New	6,413 $217,000

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.27B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Nadler Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Nadler Financial Group, Inc. with notifications on news.